A 16-year Remained UroLume Stent without any Complication; a Case Report
23 February 2021
Lumen diameter reduction which is called urethral stricture has several causative agents including iatrogenic, inflammatory, traumatic and idiopathic factors. The main treatment options are transurethral or open surgical interventions. The UroLume which was introduced around 33 years ago is an intraurethral stent and as a temporary treatment approach has a maximum 9-month durability, but hare we present the first ever reported forgotten 16-year remained UroLume without any complication.
- Urethral Stricture
- Prostatic Hyperplasia
How to Cite
2. Abdeen BM, Badreldin AM. Urethral Strictures. StatPearls [Internet]. 2020.
3. Alwaal A, Blaschko S, McAninch J, Breyer B. Epidemiology of urethral strictures. Transl Androl Urol 2014; 3: 209–13.
4. Tritschler S, Roosen A, Füllhase C, Stief CG, Rübben H. Urethral stricture: etiology, investigation and treatments. Deutsches Ärzteblatt International. 2013;110(13):220.
5. Frankiewicz M, Karolina M, Marcin M. Diagnosis and Management of Urolume Urethral Stent Complications Using Ultrasonography and Magnetic Resonance Imaging. Urology. 2020;144:e4-e5.
6. Botelho F, Thomas AA, Miocinovic R, Angermeier KW. Endoscopic removal of a proximal urethral stent using a holmium laser: Case report and literature review. Urology annals. 2012;4(3):191.
7. CORUJO M, BADLANI GH. Uncommon complications of permanent stents. Journal of endourology. 1998;12(4):385-8.
8. McNamara ER, Webster GD, Peterson AC. The UroLume stent revisited: the Duke experience. Urology. 2013;82(4):933-6.
- Abstract Viewed: 0 times
- Just Accepted/6874 Downloaded: 0 times